TY - JOUR
T1 - Surgical site infection in orthopedic trauma
T2 - A case-control study evaluating risk factors and cost
AU - Thakore, Rachel V.
AU - Greenberg, Sarah E.
AU - Shi, Hanyuan
AU - Foxx, Alexandra M.
AU - Francois, Elvis L.
AU - Prablek, Marc A.
AU - Nwosu, Samuel K.
AU - Archer, Kristin R.
AU - Ehrenfeld, Jesse M.
AU - Obremskey, William T.
AU - Sethi, Manish K.
PY - 2015
Y1 - 2015
N2 - Background: With the shift of our healthcare system toward a value-based system of reimbursement, complications such as surgical site infections (SSI) may not be reimbursed. The purpose of our study was to investigate the costs and risk factors of SSI for orthopedic trauma patients. Methods: Through retrospective analysis, 1819 patients with isolated fractures were identified. Of those, 78 patients who developed SSIs were compared to 78 uninfected control patients. Patients were matched by fracture location, type of fracture, duration of surgery, and as close as possible to age, year of surgery, and type of procedure. Costs for treatment during primary hospitalization and initial readmission were determined and potential risk factors were collected from patient charts. A Wilcoxon test was used to compare the overall costs of treatment for case and control patients. Costs were further broken down into professional fees and technical charges for analysis. Risk factors for SSIs were analyzed through a chi-squared analysis. Results: Median cost for treatment for patients with SSIs was $108,782 compared to $57,418 for uninfected patients (p
AB - Background: With the shift of our healthcare system toward a value-based system of reimbursement, complications such as surgical site infections (SSI) may not be reimbursed. The purpose of our study was to investigate the costs and risk factors of SSI for orthopedic trauma patients. Methods: Through retrospective analysis, 1819 patients with isolated fractures were identified. Of those, 78 patients who developed SSIs were compared to 78 uninfected control patients. Patients were matched by fracture location, type of fracture, duration of surgery, and as close as possible to age, year of surgery, and type of procedure. Costs for treatment during primary hospitalization and initial readmission were determined and potential risk factors were collected from patient charts. A Wilcoxon test was used to compare the overall costs of treatment for case and control patients. Costs were further broken down into professional fees and technical charges for analysis. Risk factors for SSIs were analyzed through a chi-squared analysis. Results: Median cost for treatment for patients with SSIs was $108,782 compared to $57,418 for uninfected patients (p
KW - Cost
KW - Risk factors
KW - Surgical site infection
UR - http://www.scopus.com/inward/record.url?scp=84952872957&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84952872957&partnerID=8YFLogxK
U2 - 10.1016/j.jcot.2015.04.004
DO - 10.1016/j.jcot.2015.04.004
M3 - Article
C2 - 26566333
AN - SCOPUS:84952872957
SN - 0976-5662
VL - 6
SP - 220
EP - 226
JO - Journal of Clinical Orthopaedics and Trauma
JF - Journal of Clinical Orthopaedics and Trauma
IS - 4
ER -